Humana Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the company’s TRICARE South Region contract is under objection from an unsuccessful bidder.
On February 25, 2011, the Department of Defense…
Forest Laboratories Inc. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that in March 2011, the company entered into a Stipulation of Settlement to resolve two derivative actions brought against its…
Forest Laboratories Inc. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that the company received a subpoena dated April 20, 2011 from the Office of the U.S. Attorney for the District…
Forest Laboratories Inc. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that the company (FLI) and Forest Pharmaceuticals, Inc. (FPI) remain defendants in several actions regarding overcharging of Medicaid drug reimbursement…
Forest Laboratories Inc. (FLI) and Forest Pharmaceuticals, Inc. (FPI) are named as defendants in two similar actions pending in the Missouri Circuit Court, Twenty-Second Judicial Circuit, arising from nearly identical allegations as those contained in the federal actions.
The first action,…
Forest Laboratories Inc. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission that Howard Solomon, the company’s Chairman, Chief Executive Officer and President, has received a notice from the Office of the…
Forest Laboratories Inc. continues to cooperate in an investigation of the U.S. Attorney’s Office for the District of Massachusetts related to its commercial relationship with Omnicare, Inc. (Omnicare), a long-term care pharmacy provider, the company disclosed in its latest annual…
Boston Scientific Corporation disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the parties in Guidant’s False Claims Act suit were scheduled to report the status of finalizing the settlement papers…
Boston Scientific Corporation disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on March 31, 2011, the U.S. District Court for the Northern District of Texas issued an order granting the…
The Average Wholesale Price litigation in Kansas is set for trial in August 2012, McKesson Corp. disclosed in its latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission.
Beginning in September 2010, a series of suits…